Teva Pharmaceuticals to pay $225 million to settle price-fixing charges
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: Only post material that’s relevant to the topic being discussed. Avoid profanity, slander or personal attacks
directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Teva Pharmaceuticals agrees to pay $225 million fine to settle price-fixing chargesTeva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. said Monday that it has reached an agreement with the U.S. Department of...
Read more »
Teva to pay $225 million in fines and divest generic drug to resolve price-fixing chargesIt's the latest resolution in a string of cases related to price-fixing, referring to competitors banding together to artificially set the price of a product.
Read more »
Teva Agrees to Pay $225 Million to Settle U.S. Price-Fixing ChargesThe generic drugmaker’s U.S. unit also must sell drug line for cholesterol treatment pravastatin.
Read more »
Maiden Pharmaceuticals: Fury in The Gambia a year after cough syrup deathsGrieving parents say regulators in both India and The Gambia failed their young children.
Read more »
Explainer-How airlines cope with price surge during disasters By ReutersExplainer-How airlines cope with price surge during disasters
Read more »
Boehringer latest to sue US over drug price negotiation plan By ReutersBoehringer latest to sue US over drug price negotiation plan
Read more »